Universitätsspital Zürich (USZ)

Hospital


Location: Zürich (Zurich), Switzerland (CH) CH

ISNI: 0000000404789977

ROR: https://ror.org/01462r250

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation (2021) Györfi AH, Matei AE, Fuchs M, Liang C, Rigau A, Hong X, Zhu H, et al. Journal article The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohort (2021) Hernández J, Jordan S, Dobrota R, Iudici M, Hasler P, Ribi C, Villiger P, et al. Journal article Development of randomized trials in adults with medulloblastoma—the example of eortc 1634-btg/noa-23 (2021) Hau P, Frappaz D, Hovey E, Mccabe MG, Pajtler KW, Wiestler B, Seidel C, et al. Journal article A randomized trial of a transglutaminase 2 inhibitor for celiac disease (2021) Schuppan D, Mäki M, Lundin KE, Isola J, Friesing-Sosnik T, Taavela J, Popp A, et al. Journal article Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Two-, Three-, or Four-tiered Grading of Chromophobe Renal Cancer: That's the Question! (2021) Ohashi R, Hartmann A, Martignoni G, Moch H Journal article Prevalence and characteristics of test anxiety in first year anatomy students (2021) Bischofsberger L, Burger PH, Hammer A, Paulsen F, Scholz M, Hammer C Journal article ENGRAILED 1 COORDINATES CYTOSKELETAL ORGANIZATION TO PROMOTE MYOFIBROBLAST DIFFERENTIATION AND FIBROTIC TISSUE REMODELING (2021) Györfi AH, Matei AE, Fuchs M, Rigau A, Hong X, Honglin Z, Luber M, et al. Conference contribution 68GA-FAPI-04 PET/CT STUDY EXTENSION FOR THE ASSESSMENT OF FIBROBLAST ACTIVATION AND RISK EVALUATION IN SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE (2021) Bergmann C, Distler J, Treutlein C, Tascilar K, Müller A, Atzinger A, Matei AE, et al. Conference contribution PATIENT PREFERENCES, TRADE-OFFS AND ACCEPTABLE RISKS IN THE TREATMENT OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A STEP TOWARDS SHARED DECISION-MAKING (2021) Bruni C, Heidenreich S, Duenas A, Hoffmann-Vold AM, Gabrielli A, Allanore Y, Chatelus E, et al. Conference contribution Survey within the German Society for Radiation Oncology (DEGRO) on the Diagnosis and Treatment of Salivary Gland Carcinomas (2021) Von Der Gruen J, Roedel C, Balermpas P, Martin D, Semrau S, Fietkau R, Haderlein M Conference contribution